The avidity of tumor ‐specific T cells amplified by a pDC‐based assay can predict the clinical evolution of melanoma patients

This article is protected by copyright. All rights reserved.

Source: Pigment Cell Research - July 1, 2017 Category: Cytology Authors: Julie Charles, Laurence Chaperot, Bruno Revol, Marine Baudin, Stephane Mouret, Agnes Hamon, Marie ‐Therese Leccia, Joel Plumas, Caroline Aspord Tags: Original Article Source Type: research